Portal de investigación
Prevalence of germline MUTYH mutations among Lynch-like syndrome patients
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Castillejo A
- Vargas G
- Castillejo MI
- Barberá VM
- González S
- Hernández-Illán E
- Brunet J
- Ramón y Cajal T
- Balmaña J
- Iglesias S
- Velasco A
- Solanes A
- Campos O
- Sánchez Heras AB
- Gallego J
- Carrasco E
- González Juan D
- Juan MJ
- Lázaro C
- Blanco I
- Pineda M
- Capellá G
- Soto JL
Grupos
Abstract
Background and aims: Individuals with tumours showing mismatch repair (MMR) deficiency not linked to germline mutations or somatic methylation of MMR genes have been recently referred as having lynch-like syndrome' (LLS). The genetic basis of these LLS cases is unknown. MUTYH-associated polyposis patients show some phenotypic similarities to Lynch syndrome patients. The aim of this study was to investigate the prevalence of germline MUTYH mutations in a large series of LLS patients. Methods: Two hundred and twenty-five probands fulfilling LLS criteria were included in this study. Screening of MUTYH recurrent mutations, whole coding sequencing and a large rearrangement analysis were undertaken. Age, sex, clinical, pathological and molecular characteristics of tumours including KRAS mutations were assessed. Results: We found a prevalence of 3.1% of MAP syndrome in the whole series of LLS (7/225) and 3.9% when only cases fulfilling clinical criteria were considered (7/178). Patients with MUTYH biallelic mutations had more adenomas than monoallelic (P = 0.02) and wildtype patients (P < 0.0001). Six out of nine analysed tumours from six biallelic MUTYH carriers harboured KRAS-p.G12C mutation. This mutation was found to be associated with biallelic MUTYH germline mutation when compared with reported series of unselected colorectal cancer cohorts (P < 0.0001). Conclusions: A proportion of unexplained LLS cases is caused by biallelic MUTYH mutations. The obtained results further justify the inclusion of MUTYH in the diagnostic strategy for Lynch syndrome-suspected patients. (C) 2014 Elsevier Ltd. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0959-8049, 1879-0852
- Tipo:
- Article
- Páginas:
- 2241-2250
- PubMed:
- 24953332
- Factor de Impacto:
- 2,608 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
EUROPEAN JOURNAL OF CANCER ELSEVIER SCI LTD
Citas Recibidas en Web of Science: 58
Documentos
- No hay documentos
Filiaciones
Keywords
- Lynch syndrome; MAP syndrome; MUTYH; KRAS mutations
Campos de Estudio
Cita
Castillejo A,Vargas G,Castillejo MI,NAVARRO M,Barberá VM,González S,Hernández E,Brunet J,Ramón YT,Balmaña J,OLTRA S,Iglesias S,Velasco A,Solanes A,Campos O,Sánchez AB,Gallego J,Carrasco E,González D,SEGURA A,CHIRIVELLA I,Juan MJ,TENA I,Lázaro C,Blanco I,Pineda M,Capellá G,Soto JL. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients. Eur. J. Cancer. 2014. 50. (13):p. 2241-2250. IF:5,417. (1).